semaglutide slows digestion What is Semaglutide? The Science Behind This Powerful Peptide Is GLP-1 the Same as

This information helps your provider assess your current metabolic status and anticipate potential side effects

Contact your provider if your vial expires before you finish it

Graves disease, an autoimmune thyroid disorder causing hyperthyroidism, affects approximately 0.5-1% of Americans and often leads to metabolic changes including weight fluctuations

Editors Note: This article is part of MOAAs 2024-25 TRICARE Guide, brought to you by MOAA Insurance Plans, administered by Association Member Benefits Advisors (AMBA)

Pending regulatory approval, Novo Nordisk announced that semaglutide could become the first oral formulation of a glucagon-like peptide-1 (GLP-1) indicated for chronic weight management